Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
T-Cell
Sort By
Newest First
1 / 1
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Catalent
PAO-12-20-CL-01
Dec 16, 2020
Strategic Collaboration
Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
Bayer
PR-M11-20-030
Dec 10, 2020
Natural Killer T cells
Combating Cancer and Other Diseases with Supercharged NKT Cells
Theresa Deisher, Ph.D.
AVM Biotechnology
PAP-Q4-20-CL-005
Dec 09, 2020
In Conversation
NantKwest — Harnessing Natural Killer Cells to Treat Cancer
Emilie Branch; Gary Lord; Dago Caceres; Patrick Soon-Shiong, M.D.
Pharma's Almanac
PAP-Q1-20-CL-016
Mar 19, 2020
T-Cell
Promoting T-Cell Survival
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-008
Jul 01, 2019
Immunotherapy
Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
Syntrix Pharmaceuticals
PR-M04-19-NI-040
Apr 11, 2019
Oncology
Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer
Marc Technow
Nice Insight
PAO-M03-18-NI-020
Mar 23, 2018
CAR T
Thermo Fisher Gets Key Customer for Its Cell Therapy Activation Reagents
Nice Insight
PAO-M01-18-NI-006
Jan 04, 2018
Drug Development
Memory T Cells Fit to be Cross Trained
Nice Insight
PAO-M12-17-NI-027
Dec 19, 2017
Partnership
Magnetic Bead Technology Activates Novartis’ CAR-T Therapy
Nigel Walker
Nice Insight
PAO-M09-17-NI-007
Sep 05, 2017
Innovation
Research Collaboration Will Focus on the Development of New CAR T-Cell Treatments
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-17-NI-007
Jul 07, 2017
1 / 1
